PATENT CLAIM ANALYSIS

Application Number: 16072992
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "250000"]

Abstract:
The present invention relates to a trabectedin-inclusive injectable pharmaceutical composition for gastrointestinal external use and a method for manufacturing the same. Specifically, the composition contains trabectedin and a first excipient, the first excipient being selected from one or more of monosaccharide or polylols. The preparation in the present invention has a stable quality, and can be applied to mass production.

Claim (Index 3):
The composition according to  claim 1 , further comprising a second excipient, wherein the second excipient is a polymer material.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 95.0
- Lexical Diversity: 1.46667
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14901249', '14508488', '15144884', '13610335', '12746164']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7409972206570167
- 35 USC 102 Novelty (BERT): 0.5186588557792378
- Combined Prediction Score: 0.7187633841692388
- Mean Citation Score: 218.90102
- Max Citation Score: 226.23906
- Similarity Product: 112.7206736631274

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test